Mean corpuscular volume (MCV) values reflect therapeutic effectiveness in zidovudine-receiving HIV patients.

about

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era

P2860

Q36654580-E92AEE9F-1FF3-4FE2-AF51-48B087F08AE2

P2860

Mean corpuscular volume (MCV) values reflect therapeutic effectiveness in zidovudine-receiving HIV patients.

Item

http://www.wikidata.org/entity/Q42269389

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Mean corpuscular volume (MCV) ...... vudine-receiving HIV patients.

@en

type

Item

label

Mean corpuscular volume (MCV) ...... vudine-receiving HIV patients.

@en

prefLabel

Mean corpuscular volume (MCV) ...... vudine-receiving HIV patients.

@en

P1476

Mean corpuscular volume (MCV) ...... ovudine-receiving HIV patients

@en

P2093

Ah Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Eun-Jee Oh

http://www.w3.org/2001/XMLSchema#string

Kyungja Han

http://www.w3.org/2001/XMLSchema#string

Woori Jang

http://www.w3.org/2001/XMLSchema#string

Yeon-Joon Park

http://www.w3.org/2001/XMLSchema#string

Yonggoo Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

NRTI induced mitochondrial toxicity as a mechanism for HAART related lipodystrophy: fact or fiction?

Macrocytosis as an indicator of medication (zidovudine) adherence in patients with HIV infection.

Mean Corpuscular Volume as a Marker for Adherence to Zidovudine-Containing Therapy in HIV-Infected Adults.

Mitochondrial toxicity of nucleoside analogues: mechanism, monitoring and management.

Adipocyte differentiation, mitochondrial gene expression and fat distribution: differences between zidovudine and tenofovir after 6 months.

Mean cell volume (MCV) changes in HIV-positive patients taking nucleoside reverse transcriptase inhibitors (NRTIs): a surrogate marker for adherence.

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.

Increased red cell corpuscular volume and hepatic mitochondrial function in NRTI-treated HIV infected patients.

Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression.

P304

373-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCLA.21613

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24038222

http://www.w3.org/2001/XMLSchema#string

P932

6807437

http://www.w3.org/2001/XMLSchema#string

Mean corpuscular volume (MCV) values reflect therapeutic effectiveness in zidovudine-receiving HIV patients.

about

P2860

P2860

Mean corpuscular volume (MCV) values reflect therapeutic effectiveness in zidovudine-receiving HIV patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932